Generic Name: Roflumilast
Milast is a selective phosphodiesterase 4 inhibitor indicated as a treatment to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations.
Strength: 500 mcg
Pack Size: 10’s
Dosage Form: Tablets
Therapeutic Class: Phosphodiesterase 4 inhibitor (PDE4 Inhibitor)